Literature DB >> 30674378

Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis.

C Laxmeshwar1, A G Stewart2, A Dalal3, A M V Kumar4, S Kalaiselvi5, M Das1, N Gawde6, S S Thi1, P Isaakidis7.   

Abstract

SETTING: Two drug-resistant tuberculosis (DR-TB) sites (MSF Clinic, Jupiter Hospital) in Mumbai, India.
OBJECTIVE: To assess health-related quality of life (HRQoL) and associated factors among DR-TB patients and explore their perspectives about HRQoL.
DESIGN: We used a mixed-methods design: a quantitative cross-sectional questionnaire (the World Health Organization's Quality of Life Brief Questionnaire [WHOQoL-BREF]); and qualitative in-depth interviews for purposively selected patients. Assessments were conducted between April and November 2016.
RESULTS: Ninety-five patients completed WHOQoL-BREF; 12 were interviewed. The psychological and physical health domains were the most affected (mean scores 56.2 ± standard deviation [SD] 18.3, and 56.5 ± SD 15.1, respectively; maximum 100). The social relations and environmental domains mean scores were respectively 68.6 (SD ±21.1) and 60.3 (SD ±15.9). Loss of jobs due to TB adversely affected the social relations and environmental domains. Qualitative analysis showed that support was the most important theme affecting quality of life. Other themes were physical factors (e.g., treatment adverse events), psychological factors (e.g., depression), social functioning (e.g., fear of stigmatisation) and environmental factors (e.g., health systems).
CONCLUSION: HRQoL was lower among study participants, but not as low as previously reported among TB patients. Support was the main factor that positively affected HRQoL, although both disease and treatment were physically and socially challenging.

Entities:  

Year:  2019        PMID: 30674378     DOI: 10.5588/ijtld.18.0149

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

1.  Effect of targeted nursing intervention plus psychological counseling on quality of life, negative emotions, and complications in patients with extensively drug-resistant tuberculosis.

Authors:  Yanhua Lu; Hongqian Wang; Jianfeng Zhu; Na Wang; Dan Cui; Lingdi Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB).

Authors:  Holly A Taylor; David W Dowdy; Alexandra R Searle; Andrea L Stennett; Vadim Dukhanin; Alice A Zwerling; Maria W Merritt
Journal:  SSM Qual Res Health       Date:  2022-01-28

3.  Health-Related Quality of Life of Tuberculosis Patients and the Role of Socioeconomic Factors: A Mixed-Method Study.

Authors:  Muhammad Rafiq; Shahab E Saqib; Muhammad Atiq
Journal:  Am J Trop Med Hyg       Date:  2021-10-04       Impact factor: 3.707

Review 4.  Quality of drug-resistant tuberculosis care: Gaps and solutions.

Authors:  Zarir Udwadia; Jennifer Furin
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-04-24

5.  Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China.

Authors:  Abela Mpobela Agnarson; Xiao Chun Wang; Ravi Potluri; Hitesh Bhandari; Amit Dhir; Chrispin Kambili; Laurent Metz
Journal:  BMC Infect Dis       Date:  2020-02-10       Impact factor: 3.090

6.  Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.

Authors:  Vijay Vinayak Chavan; Alpa Dalal; Sharath Nagaraja; Pruthu Thekkur; Homa Mansoor; Augusto Meneguim; Roma Paryani; Pramila Singh; Stobdan Kalon; Mrinalini Das; Gabriella Ferlazzo; Petros Isaakidis
Journal:  PLoS One       Date:  2020-06-16       Impact factor: 3.240

Review 7.  Quality of life with tuberculosis.

Authors:  Ashutosh N Aggarwal
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-09-20

8.  "A very humiliating illness": a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa.

Authors:  Jennifer Furin; Marian Loveday; Sindisiwe Hlangu; Lindy Dickson-Hall; Sacha le Roux; Mark Nicol; Helen Cox
Journal:  BMC Public Health       Date:  2020-01-17       Impact factor: 4.135

9.  Preparedness of outpatient health facilities for ambulatory treatment with all-oral short DR-TB treatment regimens in Zhytomyr, Ukraine: a cross-sectional study.

Authors:  Tinne Gils; Chinmay Laxmeshwar; Marve Duka; Khachatur Malakyan; Olga Valentinovna Siomak; Vitaly Stephanovich Didik; Natalia Lytvynenko; Yana Terleeva; Dmytri Donchuk; Petros Isaakidis
Journal:  BMC Health Serv Res       Date:  2020-09-21       Impact factor: 2.655

10.  Health-Related Quality of Life in Tuberculosis Patients in Eritrea: Comparison Among Drug-Susceptible and Rifampicin/Multidrug-Resistant Tuberculosis Patients.

Authors:  Zenawi Zeramariam Araia; Araia Berhane Mesfin; Amanuel Hadgu Mebrahtu; Adiam Ghebreyohanns Tewelde; Asmerom Tesfagiorgis Tewelde; Solyana Ngusbrhan Kidane
Journal:  Patient Relat Outcome Meas       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.